This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Genhealth Pharma Co., Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations of Li-Jie Hsu in Myocardial Regeneration
Introduction
Li-Jie Hsu is a notable inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of myocardial regeneration. His innovative work has the potential to impact the treatment of heart-related conditions.
Latest Patents
Li-Jie Hsu holds a patent for "Myocardial regeneration promoting compounds, preparation method thereof, and pharmaceutical composition." This invention discloses a novel series of 3-aryl-2-propen-1-one derivatives and their synthesis processes. The patent also details the use of these derivatives as a pharmaceutical composition aimed at promoting myocardial regeneration. He has 1 patent to his name.
Career Highlights
Li-Jie Hsu is currently associated with Genhealth Pharma Co., Ltd., where he continues to advance his research and development efforts. His work at the company focuses on innovative solutions for health challenges, particularly in regenerative medicine.
Collaborations
Some of his notable coworkers include Lain-Tze Lee and Hui-Ping Tsai, who contribute to the collaborative efforts in their research projects.
Conclusion
Li-Jie Hsu's contributions to myocardial regeneration through his innovative patent highlight the importance of research in advancing medical treatments. His work exemplifies the potential of pharmaceutical innovations to improve health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile